Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug approved in Canada for addressing Attention-Deficit/Hyperactivity Disorder (ADHD) in youngsters and people. It's functions as a prodrug, meaning https://sandozlisdexamfetaminein066536.gynoblog.com/42180505/vyvanse-in-this-country-a-comprehensive-guide